Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-20-012150
Filing Date
2020-06-22
Accepted
2020-06-22 21:55:45
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp130796_4-legorreta.html 4  
1 FORM 4 dp130796_4-legorreta.xml 4 35974
  Complete submission text file 0000950103-20-012150.txt   37392
Mailing Address 110 E 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address
Legorreta Pablo G. (Reporting) CIK: 0001507678 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 20980183

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations